Friday, November 29, 2019
Home »
» Medical News Today: One ketamine shot could help heavy drinkers cut down
Medical News Today: One ketamine shot could help heavy drinkers cut down
An experimental study shows that a single shot of ketamine helps reduce drinking cravings, particularly after the retrieval of associated reward memories.
Related Posts:
2023 Healthy Kentucky Champion nominations are due May 1 The deadline to nominate someone for a 2023 Healthy Kentucky Champion award is Monday, May 1. The award, sponsored by the Foundation for a Health Kentucky, is meant to recognize people leading the change to improve t… Read More
UK medical school and recently added regional campuses will graduate largest class ever, with 42% staying in Ky. for residency Students in this year's graduating class of the University of Kentucky College of Medicine at Lexington celebrated Match Day in March, when they learned their residency locations. (UK photo by Mark Mahan) By Allison … Read More
First round of state grants from settlements with opioid makers and distributors, more than $8 million, go to 24 organizations Operation UNITE was one of 24 organizations to get a grant from the first round of opioid settlement money. It got $1 million to be used for prevention. (Photos by Melissa Patrick) By Melissa Patrick Kentucky Health… Read More
Kentucky's Covid-19 death rate lower than U.S. average when adjusted for health conditions and average ages in the states Rates before (L) and after (R) adjustment for conditions; click image to enlarge By Melissa Patrick Kentucky Health News Now that Covid-19 has gone beyond the pandemic phase to the endemic phase, how did Kentucky han… Read More
UK study finds children who were exposed to opioids before birth are more likely to develop chronic diseases when they grow upBy Lindsay Travis University of Kentucky What happens to the cardiovascular health of babies exposed to opioids in the womb? A new study at the University of Kentucky suggests that children born to mothers who use opioids d… Read More
0 comments:
Post a Comment